Afya Limited (NASDAQ:AFYA) Position Reduced by Bamco Inc. NY

Bamco Inc. NY lowered its stake in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 6.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,526,643 shares of the company's stock after selling 174,832 shares during the period. Bamco Inc. NY owned approximately 2.70% of Afya worth $43,130,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in AFYA. Erste Asset Management GmbH purchased a new position in shares of Afya in the 3rd quarter worth about $822,000. PDT Partners LLC purchased a new position in Afya in the third quarter valued at approximately $481,000. Quantbot Technologies LP lifted its position in Afya by 73.8% during the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company's stock valued at $226,000 after buying an additional 5,636 shares in the last quarter. Lifestyle Asset Management Inc. grew its stake in Afya by 13.3% during the third quarter. Lifestyle Asset Management Inc. now owns 16,753 shares of the company's stock worth $286,000 after buying an additional 1,969 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new stake in shares of Afya in the third quarter worth $417,000. Institutional investors and hedge funds own 88.02% of the company's stock.

Afya Stock Down 3.8 %

Afya stock traded down $0.63 during midday trading on Tuesday, hitting $15.96. 317,149 shares of the stock were exchanged, compared to its average volume of 113,868. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.60 and a quick ratio of 1.60. The company has a 50 day moving average price of $16.80 and a two-hundred day moving average price of $17.11. The firm has a market cap of $1.50 billion, a P/E ratio of 12.87, a P/E/G ratio of 0.34 and a beta of 0.89. Afya Limited has a 1 year low of $15.28 and a 1 year high of $22.48.

Analyst Ratings Changes

Several research firms recently weighed in on AFYA. UBS Group assumed coverage on shares of Afya in a report on Friday, August 30th. They set a "neutral" rating and a $19.50 target price on the stock. The Goldman Sachs Group began coverage on Afya in a research note on Tuesday. They issued a "sell" rating and a $16.00 target price for the company.

Afya Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.